iCoreConnect Inc. (ICCT)
USD 3.26
(-36.2%)
USD 3.26
(-36.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -11.87 Million USD | -124.91% |
| 2022 | -3.51 Million USD | -32.0% |
| 2021 | -1.51 Million USD | -27.24% |
| 2020 | -2.34 Million USD | 14.56% |
| 2019 | -2.09 Million USD | 38.72% |
| 2018 | -4.55 Million USD | -131.84% |
| 2017 | -1.96 Million USD | 0.0% |
| 2014 | -3.3 Million USD | 54.65% |
| 2013 | 3.18 Million USD | -250.38% |
| 2012 | -6.78 Million USD | -104.37% |
| 2011 | -2.78 Million USD | 56.16% |
| 2010 | -4.23 Million USD | 52.31% |
| 2009 | -4.92 Million USD | 16.78% |
| 2008 | -5.66 Million USD | -31.74% |
| 2007 | -5.56 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.7 Million USD | -296.97% |
| 2024 Q1 | -2.3 Million USD | 64.42% |
| 2023 FY | - USD | -124.91% |
| 2023 Q3 | -2.47 Million USD | -15.3% |
| 2023 Q4 | -4.01 Million USD | -62.51% |
| 2023 Q2 | -2.14 Million USD | -87.81% |
| 2023 Q1 | -1.14 Million USD | -0.8% |
| 2022 Q2 | -957.69 Thousand USD | -2.89% |
| 2022 Q1 | -930.77 Thousand USD | 58.74% |
| 2022 FY | - USD | -32.0% |
| 2022 Q4 | -1.13 Million USD | -26.07% |
| 2022 Q3 | -898.83 Thousand USD | 6.15% |
| 2021 Q2 | -290.22 Thousand USD | 26.04% |
| 2021 Q1 | -392.42 Thousand USD | 49.23% |
| 2021 FY | - USD | -27.24% |
| 2021 Q4 | -2.25 Million USD | -474.31% |
| 2021 Q3 | -392.77 Thousand USD | -35.34% |
| 2020 Q4 | -773 Thousand USD | -57.76% |
| 2020 Q2 | -598 Thousand USD | -14.56% |
| 2020 FY | - USD | 14.56% |
| 2020 Q1 | -522 Thousand USD | 49.9% |
| 2020 Q3 | -490 Thousand USD | 18.06% |
| 2019 Q1 | -605 Thousand USD | -15.24% |
| 2019 Q3 | -599 Thousand USD | -10.72% |
| 2019 Q4 | -1.04 Million USD | -73.96% |
| 2019 FY | - USD | 38.72% |
| 2019 Q2 | -541 Thousand USD | 10.58% |
| 2018 Q1 | -2.14 Million USD | -116.34% |
| 2018 Q4 | -525 Thousand USD | -14.88% |
| 2018 Q3 | -457 Thousand USD | 67.88% |
| 2018 Q2 | -1.42 Million USD | 33.66% |
| 2018 FY | - USD | -131.84% |
| 2017 Q4 | -991.5 Thousand USD | -117.43% |
| 2017 Q2 | -545 Thousand USD | 3.8% |
| 2017 Q1 | -566.5 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | -456 Thousand USD | 16.33% |
| 2015 Q1 | -805.75 Thousand USD | -11.62% |
| 2014 FY | - USD | 54.65% |
| 2014 Q2 | -1.79 Million USD | -851.75% |
| 2014 Q1 | -188.65 Thousand USD | 72.38% |
| 2014 Q4 | -721.85 Thousand USD | 47.47% |
| 2014 Q3 | -1.37 Million USD | 23.46% |
| 2013 Q3 | -641.88 Thousand USD | -1483.91% |
| 2013 Q4 | -683.03 Thousand USD | -6.41% |
| 2013 FY | - USD | -250.38% |
| 2013 Q1 | -5.79 Million USD | -776.11% |
| 2013 Q2 | -40.52 Thousand USD | 99.3% |
| 2012 Q3 | -396.12 Thousand USD | 71.07% |
| 2012 Q4 | -661.4 Thousand USD | -66.97% |
| 2012 FY | - USD | -104.37% |
| 2012 Q1 | -267.15 Thousand USD | -1.7% |
| 2012 Q2 | -1.36 Million USD | -412.53% |
| 2011 Q3 | -183.51 Thousand USD | -173.46% |
| 2011 Q1 | -343.76 Thousand USD | 1.43% |
| 2011 Q4 | -262.67 Thousand USD | -43.14% |
| 2011 Q2 | 249.8 Thousand USD | 172.67% |
| 2011 FY | - USD | 56.16% |
| 2010 FY | - USD | 52.31% |
| 2010 Q2 | -459.77 Thousand USD | 51.58% |
| 2010 Q1 | -949.48 Thousand USD | -391.91% |
| 2010 Q4 | -348.74 Thousand USD | 47.78% |
| 2010 Q3 | -667.81 Thousand USD | -45.25% |
| 2009 Q4 | -193.02 Thousand USD | 88.55% |
| 2009 FY | - USD | 16.78% |
| 2009 Q3 | -1.68 Million USD | 51.22% |
| 2009 Q2 | -3.45 Million USD | -635.6% |
| 2009 Q1 | -469.8 Thousand USD | -7.82% |
| 2008 Q4 | -435.75 Thousand USD | 24.6% |
| 2008 Q3 | -577.89 Thousand USD | 79.51% |
| 2008 Q1 | -707.06 Thousand USD | 80.26% |
| 2008 Q2 | -2.82 Million USD | -298.92% |
| 2008 FY | - USD | -31.74% |
| 2007 Q2 | -2.11 Million USD | -145.74% |
| 2007 Q3 | -1.12 Million USD | 47.14% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | -3.58 Million USD | -219.67% |
| 2007 Q1 | -862.62 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Omnicell, Inc. | 60.69 Million USD | 119.574% |
| Renalytix Plc | -28.52 Million USD | 58.349% |
| Schrödinger, Inc. | -171.89 Million USD | 93.089% |
| Simulations Plus, Inc. | 6.13 Million USD | 293.759% |
| SOPHiA GENETICS SA | -70.7 Million USD | 83.197% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 7.308% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 103.399% |
| CareCloud, Inc. | -31.29 Million USD | 62.035% |
| HealthEquity, Inc. | 282.41 Million USD | 104.206% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 106.367% |
| Ontrak, Inc. | -14.41 Million USD | 17.596% |
| Minerva Surgical, Inc. | -20.07 Million USD | 40.819% |
| Nutex Health, Inc. | -14.58 Million USD | 18.53% |
| OneMedNet Corporation | -11.97 Million USD | 0.763% |
| Progyny, Inc. | 64.46 Million USD | 118.428% |
| Augmedix, Inc. | -17.68 Million USD | 32.813% |
| CareCloud, Inc. | -31.29 Million USD | 62.035% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.334% |
| Sharecare, Inc. | -67.25 Million USD | 82.337% |
| Aclarion, Inc. | -4.14 Million USD | -186.913% |
| CareMax, Inc. | -590.46 Million USD | 97.988% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | -125.199% |
| Forian Inc. | 2.75 Million USD | 531.932% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | -125.199% |
| HeartBeam, Inc. | 675 Thousand USD | 1859.91% |
| GeneDx Holdings Corp. | -136.46 Million USD | 91.295% |
| SCWorx Corp. | -3.97 Million USD | -198.876% |
| Definitive Healthcare Corp. | -241.22 Million USD | 95.075% |
| 10x Genomics, Inc. | -205.11 Million USD | 94.208% |
| Zhongchao Inc. | -4.9 Million USD | -142.32% |
| Accolade, Inc. | -71.19 Million USD | 83.314% |
| MSP Recovery, Inc. | -69.22 Million USD | 82.838% |
| R1 RCM Inc. | 426.2 Million USD | 102.787% |
| Spok Holdings, Inc. | 26.29 Million USD | 145.174% |
| Privia Health Group, Inc. | 27.18 Million USD | 143.703% |
| EUDA Health Holdings Limited | -8.3 Million USD | -43.119% |
| TruBridge, Inc. | -15.39 Million USD | 22.816% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 103.399% |
| Sharecare, Inc. | -67.25 Million USD | 82.337% |
| Health Catalyst, Inc. | -66.46 Million USD | 82.126% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 110.916% |
| Premier, Inc. | 286.08 Million USD | 104.152% |
| HealthStream, Inc. | 59.58 Million USD | 119.936% |
| Certara, Inc. | 23.84 Million USD | 149.821% |
| GeneDx Holdings Corp. | -136.46 Million USD | 91.295% |
| Ontrak, Inc. | -14.41 Million USD | 17.596% |
| SHL Telemedicine Ltd. | 3.28 Million USD | 461.789% |
| CareCloud, Inc. | -31.29 Million USD | 62.035% |
| EUDA Health Holdings Limited | -8.3 Million USD | -43.119% |
| HeartBeam, Inc. | 675 Thousand USD | 1859.91% |
| Mangoceuticals, Inc. | -9.18 Million USD | -29.299% |
| CareMax, Inc. | -590.46 Million USD | 97.988% |
| Healthcare Triangle, Inc. | -4.1 Million USD | -189.459% |
| National Research Corporation | 45.98 Million USD | 125.833% |
| Aclarion, Inc. | -4.14 Million USD | -186.913% |
| OptimizeRx Corporation | -21.3 Million USD | 44.25% |